nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.0275	0.0521	CbGpPWpGaD
Fludarabine—SLC28A3—adipose tissue—polycystic ovary syndrome	0.0224	0.0524	CbGeAlD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.0212	0.0401	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.0209	0.0395	CbGpPWpGaD
Fludarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—polycystic ovary syndrome	0.02	0.0378	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide Metabolism—RRM2—polycystic ovary syndrome	0.0191	0.0362	CbGpPWpGaD
Fludarabine—SLC28A3—female gonad—polycystic ovary syndrome	0.0188	0.0438	CbGeAlD
Fludarabine—POLA1—endometrium—polycystic ovary syndrome	0.0175	0.0409	CbGeAlD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.0161	0.0304	CbGpPWpGaD
Fludarabine—POLA1—pituitary gland—polycystic ovary syndrome	0.0158	0.037	CbGeAlD
Fludarabine—POLA1—adipose tissue—polycystic ovary syndrome	0.0158	0.0368	CbGeAlD
Fludarabine—RRM1—adrenal cortex—polycystic ovary syndrome	0.0155	0.0363	CbGeAlD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.0155	0.0293	CbGpPWpGaD
Fludarabine—POLA1—G1/S-Specific Transcription—CDC6—polycystic ovary syndrome	0.0151	0.0286	CbGpPWpGaD
Fludarabine—DCK—embryo—polycystic ovary syndrome	0.0147	0.0344	CbGeAlD
Fludarabine—POLA1—adrenal gland—polycystic ovary syndrome	0.0141	0.033	CbGeAlD
Fludarabine—RRM1—endometrium—polycystic ovary syndrome	0.0139	0.0324	CbGeAlD
Fludarabine—POLA1—female gonad—polycystic ovary syndrome	0.0132	0.0308	CbGeAlD
Fludarabine—POLA1—vagina—polycystic ovary syndrome	0.0131	0.0306	CbGeAlD
Fludarabine—Clofarabine—RRM2—polycystic ovary syndrome	0.013	0.635	CrCbGaD
Fludarabine—RRM1—uterus—polycystic ovary syndrome	0.0128	0.0299	CbGeAlD
Fludarabine—SLC29A1—adrenal cortex—polycystic ovary syndrome	0.0126	0.0295	CbGeAlD
Fludarabine—RRM1—pituitary gland—polycystic ovary syndrome	0.0126	0.0294	CbGeAlD
Fludarabine—RRM1—adipose tissue—polycystic ovary syndrome	0.0125	0.0292	CbGeAlD
Fludarabine—RRM1—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.0123	0.0233	CbGpPWpGaD
Fludarabine—DCK—adrenal cortex—polycystic ovary syndrome	0.0121	0.0282	CbGeAlD
Fludarabine—POLA1—G1/S-Specific Transcription—RRM2—polycystic ovary syndrome	0.0118	0.0223	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.0118	0.0222	CbGpPWpGaD
Fludarabine—SLC29A1—endometrium—polycystic ovary syndrome	0.0113	0.0264	CbGeAlD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.0113	0.0213	CbGpPWpGaD
Fludarabine—RRM1—adrenal gland—polycystic ovary syndrome	0.0112	0.0262	CbGeAlD
Fludarabine—DCK—endometrium—polycystic ovary syndrome	0.0108	0.0252	CbGeAlD
Fludarabine—POLA1—Nucleotide Metabolism—RRM2—polycystic ovary syndrome	0.0108	0.0204	CbGpPWpGaD
Fludarabine—RRM1—female gonad—polycystic ovary syndrome	0.0105	0.0244	CbGeAlD
Fludarabine—SLC29A1—uterus—polycystic ovary syndrome	0.0104	0.0243	CbGeAlD
Fludarabine—RRM1—vagina—polycystic ovary syndrome	0.0104	0.0243	CbGeAlD
Fludarabine—SLC29A1—pituitary gland—polycystic ovary syndrome	0.0102	0.0239	CbGeAlD
Fludarabine—SLC29A1—adipose tissue—polycystic ovary syndrome	0.0102	0.0238	CbGeAlD
Fludarabine—DCK—uterus—polycystic ovary syndrome	0.00994	0.0232	CbGeAlD
Fludarabine—DCK—pituitary gland—polycystic ovary syndrome	0.00976	0.0228	CbGeAlD
Fludarabine—RRM1—endocrine gland—polycystic ovary syndrome	0.00973	0.0227	CbGeAlD
Fludarabine—DCK—adipose tissue—polycystic ovary syndrome	0.00972	0.0227	CbGeAlD
Fludarabine—POLA1—Activation of the pre-replicative complex—CDC6—polycystic ovary syndrome	0.00958	0.0181	CbGpPWpGaD
Fludarabine—SLC29A1—adrenal gland—polycystic ovary syndrome	0.00913	0.0213	CbGeAlD
Fludarabine—RRM1—E2F transcription factor network—CCNE2—polycystic ovary syndrome	0.00889	0.0168	CbGpPWpGaD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—CDC6—polycystic ovary syndrome	0.00888	0.0168	CbGpPWpGaD
Fludarabine—DCK—adrenal gland—polycystic ovary syndrome	0.00872	0.0204	CbGeAlD
Fludarabine—SLC29A1—female gonad—polycystic ovary syndrome	0.00851	0.0199	CbGeAlD
Fludarabine—SLC29A1—vagina—polycystic ovary syndrome	0.00846	0.0198	CbGeAlD
Fludarabine—RRM1—E2F transcription factor network—CDC6—polycystic ovary syndrome	0.00835	0.0158	CbGpPWpGaD
Fludarabine—DCK—female gonad—polycystic ovary syndrome	0.00813	0.019	CbGeAlD
Fludarabine—DCK—vagina—polycystic ovary syndrome	0.00808	0.0189	CbGeAlD
Fludarabine—SLC29A1—endocrine gland—polycystic ovary syndrome	0.00791	0.0185	CbGeAlD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00772	0.0146	CbGpPWpGaD
Fludarabine—DCK—endocrine gland—polycystic ovary syndrome	0.00756	0.0177	CbGeAlD
Fludarabine—Cladribine—RRM2—polycystic ovary syndrome	0.00746	0.365	CrCbGaD
Fludarabine—POLA1—DNA Replication—CDC6—polycystic ovary syndrome	0.00732	0.0139	CbGpPWpGaD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—RRM2—polycystic ovary syndrome	0.00693	0.0131	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.00673	0.0127	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—RRM2—polycystic ovary syndrome	0.00652	0.0123	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.00622	0.0118	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.00619	0.0117	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00594	0.0112	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.00569	0.0108	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.00567	0.0107	CbGpPWpGaD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—CCNB1—polycystic ovary syndrome	0.00525	0.00994	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CCNE2—polycystic ovary syndrome	0.005	0.00947	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.00477	0.00903	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.00476	0.00901	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDC6—polycystic ovary syndrome	0.00471	0.00891	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00461	0.00872	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.00436	0.00825	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00435	0.00823	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication Pre-Initiation—CDC6—polycystic ovary syndrome	0.00433	0.00819	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.0043	0.00813	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.00379	0.00718	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDC6—polycystic ovary syndrome	0.00378	0.00715	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—RRM2—polycystic ovary syndrome	0.00367	0.00695	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.00367	0.00695	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00367	0.00694	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CCNE2—polycystic ovary syndrome	0.00363	0.00687	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—CDC6—polycystic ovary syndrome	0.00355	0.00671	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00343	0.0065	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDC6—polycystic ovary syndrome	0.00341	0.00646	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.00331	0.00626	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCNE2—polycystic ovary syndrome	0.0033	0.00624	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00328	0.00621	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.00319	0.00604	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDC6—polycystic ovary syndrome	0.0031	0.00587	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.00306	0.00579	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00297	0.00562	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.00288	0.00545	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.00269	0.00509	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—RRM2—polycystic ovary syndrome	0.00267	0.00504	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—RAB2A—polycystic ovary syndrome	0.00261	0.00494	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00254	0.00481	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00245	0.00463	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.00242	0.00458	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.00241	0.00456	CbGpPWpGaD
Fludarabine—Respiratory distress—Metformin—polycystic ovary syndrome	0.00234	0.101	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.00225	0.00425	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00221	0.00419	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00207	0.00392	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00207	0.00391	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CCNB1—polycystic ovary syndrome	0.00202	0.00382	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00198	0.00374	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.00195	0.0037	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—TOP2A—polycystic ovary syndrome	0.00189	0.00358	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—RAB2A—polycystic ovary syndrome	0.00175	0.00331	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.0017	0.00322	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00168	0.00319	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00157	0.00297	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00155	0.00292	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00143	0.00271	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SUOX—polycystic ovary syndrome	0.00143	0.00271	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00143	0.00271	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—CDC6—polycystic ovary syndrome	0.00141	0.00267	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.00136	0.00257	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00133	0.00252	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00124	0.00234	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NMNAT3—polycystic ovary syndrome	0.00121	0.00228	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00118	0.00222	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00115	0.00218	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00113	0.00214	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TEAD2—polycystic ovary syndrome	0.00113	0.00214	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.00112	0.00212	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00111	0.00211	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LPCAT2—polycystic ovary syndrome	0.0011	0.00209	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SUOX—polycystic ovary syndrome	0.0011	0.00209	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.00106	0.002	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00105	0.00199	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAD2L1—polycystic ovary syndrome	0.00104	0.00197	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.00103	0.00194	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ISYNA1—polycystic ovary syndrome	0.00103	0.00194	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCNE2—polycystic ovary syndrome	0.001	0.0019	CbGpPWpGaD
Fludarabine—Dehydration—Metformin—polycystic ovary syndrome	0.001	0.0434	CcSEcCtD
Fludarabine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000994	0.0431	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—LMNA—polycystic ovary syndrome	0.000967	0.00183	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00095	0.0018	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000949	0.0018	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDC6—polycystic ovary syndrome	0.000944	0.00179	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000924	0.00175	CbGpPWpGaD
Fludarabine—Angina pectoris—Metformin—polycystic ovary syndrome	0.000907	0.0393	CcSEcCtD
Fludarabine—Sweating increased—Metformin—polycystic ovary syndrome	0.000907	0.0393	CcSEcCtD
Fludarabine—RRM1—Metabolism—SRD5A1—polycystic ovary syndrome	0.0009	0.0017	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000884	0.00167	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TEAD2—polycystic ovary syndrome	0.000872	0.00165	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKR1C2—polycystic ovary syndrome	0.000872	0.00165	CbGpPWpGaD
Fludarabine—Neutropenia—Metformin—polycystic ovary syndrome	0.00087	0.0377	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000865	0.0375	CcSEcCtD
Fludarabine—RRM1—Metabolism—STAR—polycystic ovary syndrome	0.000859	0.00163	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000859	0.00162	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—CCNB1—polycystic ovary syndrome	0.000835	0.00158	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000824	0.00156	CbGpPWpGaD
Fludarabine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000814	0.0353	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000785	0.00149	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000778	0.00147	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000768	0.00145	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HMMR—polycystic ovary syndrome	0.000766	0.00145	CbGpPWpGaD
Fludarabine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000741	0.0321	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—RRM2—polycystic ovary syndrome	0.000737	0.00139	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PNPLA2—polycystic ovary syndrome	0.000731	0.00138	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD3B1—polycystic ovary syndrome	0.00073	0.00138	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000723	0.00137	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000696	0.00132	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000693	0.00131	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SRD5A1—polycystic ovary syndrome	0.000693	0.00131	CbGpPWpGaD
Fludarabine—Chills—Metformin—polycystic ovary syndrome	0.000669	0.029	CcSEcCtD
Fludarabine—RRM1—Metabolism—LHB—polycystic ovary syndrome	0.000666	0.00126	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000662	0.00125	CbGpPWpGaD
Fludarabine—DCK—Metabolism—STAR—polycystic ovary syndrome	0.000661	0.00125	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000659	0.00125	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000651	0.00123	CbGpPWpGaD
Fludarabine—Malnutrition—Metformin—polycystic ovary syndrome	0.000649	0.0281	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—LMNA—polycystic ovary syndrome	0.000647	0.00122	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00063	0.00119	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000624	0.00118	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TOP2A—polycystic ovary syndrome	0.00062	0.00117	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000602	0.0261	CcSEcCtD
Fludarabine—DCK—Metabolism—HMMR—polycystic ovary syndrome	0.000589	0.00111	CbGpPWpGaD
Fludarabine—Malaise—Metformin—polycystic ovary syndrome	0.000585	0.0254	CcSEcCtD
Fludarabine—RRM1—Metabolism—SULT2A1—polycystic ovary syndrome	0.00058	0.0011	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000578	0.00109	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSD3B1—polycystic ovary syndrome	0.000562	0.00106	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—RRM2—polycystic ovary syndrome	0.000562	0.00106	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000558	0.00106	CbGpPWpGaD
Fludarabine—Myalgia—Metformin—polycystic ovary syndrome	0.000552	0.0239	CcSEcCtD
Fludarabine—Discomfort—Metformin—polycystic ovary syndrome	0.000546	0.0236	CcSEcCtD
Fludarabine—RRM1—Metabolism—YAP1—polycystic ovary syndrome	0.000542	0.00103	CbGpPWpGaD
Fludarabine—Oedema—Metformin—polycystic ovary syndrome	0.000529	0.0229	CcSEcCtD
Fludarabine—Infection—Metformin—polycystic ovary syndrome	0.000526	0.0228	CcSEcCtD
Fludarabine—RRM1—Metabolism—NAMPT—polycystic ovary syndrome	0.00052	0.000985	CbGpPWpGaD
Fludarabine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000519	0.0225	CcSEcCtD
Fludarabine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000518	0.0225	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000514	0.000973	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LHB—polycystic ovary syndrome	0.000512	0.00097	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000512	0.0222	CcSEcCtD
Fludarabine—Anorexia—Metformin—polycystic ovary syndrome	0.000505	0.0219	CcSEcCtD
Fludarabine—DCK—Metabolism—HSD3B2—polycystic ovary syndrome	0.000501	0.000948	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000485	0.000918	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKR1C1—polycystic ovary syndrome	0.000485	0.000918	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000482	0.0209	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000478	0.000904	CbGpPWpGaD
Fludarabine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000475	0.0206	CcSEcCtD
Fludarabine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000472	0.0205	CcSEcCtD
Fludarabine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000466	0.0202	CcSEcCtD
Fludarabine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00046	0.0199	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000457	0.0198	CcSEcCtD
Fludarabine—Fatigue—Metformin—polycystic ovary syndrome	0.000456	0.0198	CcSEcCtD
Fludarabine—Constipation—Metformin—polycystic ovary syndrome	0.000453	0.0196	CcSEcCtD
Fludarabine—DCK—Metabolism—SULT2A1—polycystic ovary syndrome	0.000446	0.000845	CbGpPWpGaD
Fludarabine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000436	0.0189	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000432	0.000818	CbGpPWpGaD
Fludarabine—DCK—Metabolism—RRM2—polycystic ovary syndrome	0.000432	0.000818	CbGpPWpGaD
Fludarabine—DCK—Metabolism—YAP1—polycystic ovary syndrome	0.000417	0.000789	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TH—polycystic ovary syndrome	0.000413	0.000782	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000402	0.000761	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NAMPT—polycystic ovary syndrome	0.0004	0.000758	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP11A1—polycystic ovary syndrome	0.000395	0.000748	CbGpPWpGaD
Fludarabine—Asthenia—Metformin—polycystic ovary syndrome	0.00038	0.0165	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000378	0.000716	CbGpPWpGaD
Fludarabine—Pruritus—Metformin—polycystic ovary syndrome	0.000374	0.0162	CcSEcCtD
Fludarabine—DCK—Metabolism—AKR1C3—polycystic ovary syndrome	0.000373	0.000707	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP17A1—polycystic ovary syndrome	0.000368	0.000696	CbGpPWpGaD
Fludarabine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000362	0.0157	CcSEcCtD
Fludarabine—RRM1—Metabolism—GNAS—polycystic ovary syndrome	0.000337	0.000639	CbGpPWpGaD
Fludarabine—Vomiting—Metformin—polycystic ovary syndrome	0.000337	0.0146	CcSEcCtD
Fludarabine—Rash—Metformin—polycystic ovary syndrome	0.000334	0.0145	CcSEcCtD
Fludarabine—Dermatitis—Metformin—polycystic ovary syndrome	0.000333	0.0145	CcSEcCtD
Fludarabine—Headache—Metformin—polycystic ovary syndrome	0.000332	0.0144	CcSEcCtD
Fludarabine—RRM1—Metabolism—NCOR1—polycystic ovary syndrome	0.000321	0.000608	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TH—polycystic ovary syndrome	0.000318	0.000602	CbGpPWpGaD
Fludarabine—Nausea—Metformin—polycystic ovary syndrome	0.000314	0.0136	CcSEcCtD
Fludarabine—DCK—Metabolism—SLC2A4—polycystic ovary syndrome	0.000309	0.000586	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000305	0.000577	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP19A1—polycystic ovary syndrome	0.000291	0.000551	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—polycystic ovary syndrome	0.000284	0.000538	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GNAS—polycystic ovary syndrome	0.00026	0.000491	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NCOR1—polycystic ovary syndrome	0.000247	0.000468	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP1A1—polycystic ovary syndrome	0.000235	0.000444	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARG—polycystic ovary syndrome	0.00023	0.000436	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—POMC—polycystic ovary syndrome	0.000227	0.00043	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—INS—polycystic ovary syndrome	0.000226	0.000428	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—polycystic ovary syndrome	0.000219	0.000414	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARG—polycystic ovary syndrome	0.000177	0.000336	CbGpPWpGaD
Fludarabine—DCK—Metabolism—POMC—polycystic ovary syndrome	0.000175	0.000331	CbGpPWpGaD
Fludarabine—DCK—Metabolism—INS—polycystic ovary syndrome	0.000174	0.000329	CbGpPWpGaD
